Bellevue Life Sciences Ac... (BLAC)
3.01
-3.72 (-55.27%)
At close: Feb 14, 2025, 3:53 PM
2.81
-6.75%
After-hours: Feb 14, 2025, 07:59 PM EST
Company Description
Bellevue Life Sciences Acquisition Corp. does not have significant operations.
It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry.
The company was incorporated in 2020 and is based in Bellevue, Washington.
Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
Bellevue Life Sciences Acquisition Corp.
| Country | United States |
| IPO Date | Mar 21, 2023 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Kuk Hyoun Hwang |
Contact Details
Address: 10900 NE 4th Street Bellevue, Washington United States | |
| Website | https://www.bellevuespac.com |
Stock Details
| Ticker Symbol | BLAC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001840425 |
| CUSIP Number | 079174108 |
| ISIN Number | US0791741087 |
| Employer ID | 84-5052822 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Kuk Hyoun Hwang | Chief Executive Officer & Executive Chairman |
| David Jin Yoo | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 01, 2025 | NT 10-K | Filing |
| Mar 25, 2025 | 8-K | Current Report |
| Feb 28, 2025 | 8-K | Current Report |
| Feb 21, 2025 | 3 | Filing |
| Feb 21, 2025 | 3 | Filing |
| Feb 21, 2025 | 3 | Filing |
| Feb 21, 2025 | 8-K | Current Report |
| Feb 20, 2025 | 3 | Filing |
| Feb 20, 2025 | 3 | Filing |
| Feb 19, 2025 | 4 | Filing |